MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Risk Tolerance of Therapeutic Interventions in People with Parkinson’s Disease

    B. Dukes, A. Colombo, K. Patel, D. Shah-Zamora (Winston Salem, USA)

    Objective: To determine the sociodemographic factors of people with Parkinson’s disease (PD) associated with risk tolerance when considering interventions. Background: Gender and racial disparities in…
  • 2024 International Congress

    Hierarchical Machine Learning Classification of Parkinsonian Disorders using Saccades

    O. Bredemeyer, S. Patel, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: To evaluate the discriminative power of a novel saccade waveform reconstruction approach compared to conventional saccadic metrics in differentiating Parkinson's disease (PD), progressive supranuclear…
  • 2024 International Congress

    Gender specificity in AI-Based Screening Diagnostics of Parkinson’s Disease (Brainphone Project)

    D. Khasanova, I. Khasanov, G. Ilina, Z. Zalyalova (Kazan, Russian Federation)

    Objective: The aim of this part the clinical study was to obtain better understanding of the relation of efficiency AI-based screening diagnositics service for Parkinson's…
  • 2024 International Congress

    Digital health technology (DHT) derived features as sensitive measures of disease progression in early Parkinson’s disease under stable dopaminergic treatment

    F. Lipsmeier, S. Lambrecht, S. Fraessle, Y. Gazizova, D. Kwasny, P. Wacht, B. Fehlmann, T. Kustermann, M. Lindemann, W. Popp, K. Taylor, R. Postuma (Basel, Switzerland)

    Objective: To evaluate the ability of DHT derived features from remotely collected active tests to measure disease progression in individuals with early Parkinson’s disease (PD)…
  • 2024 International Congress

    Prevalence of Phosphorylated Alpha-Synuclein in Skin Biopsies of Essential Tremor Patients

    S. Bellows, N. Vanegas Arroyave, J. Jankovic (Housont, USA)

    Objective: To examine the prevalence of phosphorylated alpha-synuclein in nerve fibers in patients with essential tremor (ET) and ET plus. Background: Although Essential Tremor (ET)…
  • 2024 International Congress

    Rare Variant Burden is Increased in Sporadic Late-onset Chinese Parkinson’s Disease Patients

    RWH. Ho, ZW. Xiong, RCN. Lo, HF. Liu, PWL. Ho, SL. Ho, SYY. Pang (Hong Kong, Hong Kong)

    Objective: We aim to study the rare variant burden in a panel of 29 Parkinson’s disease (PD) candidate genes (Table 1) in a cohort of…
  • 2024 International Congress

    Genome-wide Assessment of Homozygosity in Parkinson’s Disease Across Diverse Ancestral Population

    K. Step, C. Hernandez Astudillo, E. Eltaraifee, Z-H. Fang, A. Hernández-Medrano, P-J. Kung, M. Ostrožovičová, A. Zirra, I. Sarmiento, S. Bandres-Ciga (Cape Town, South Africa)

    Objective: Our objective is to undertake the most extensive screening of the impact of homozygosity in Parkinson's disease (PD) etiology across diverse populations. We aim…
  • 2024 International Congress

    Sleep Characteristics in Idiopathic and Genetic Parkinson’s Disease

    A. Astefanous, M. Yang, D. Raymond, M. Rawal, J. Liang, A. Cohen, N. Becker, B. Plitnick, A. Yoo, V. Katsnelson, K. Leaver, S. Bressman, M. Figueiro, R. Saunders-Pullman, A. Wise (NEW YORK, USA)

    Objective: To investigate sleep features among individuals with genetic subgroups of PD, including LRRK2 G2019S-PD, GBA-PD, and iPD (idiopathic PD with no known genetic variant). Background:…
  • 2024 International Congress

    The Black and African American Connections to Parkinson’s Disease Study

    F. Akcimen, P. Crea, P. Saffie-Awad, S. Grant, R. Traurig, M. Khani, M. Makarious, K. Levine, D. Vitale, M. Koretsky, M. Nalls, Z. Fang, J. Solle, N. Louie, O. Ojo, N. Okubadejo, G. Sukumar, C. Dalgard, R. Real, H. Morris, K. Billingsley, P. Jerez, D. Hernandez, S. Arepalli, L. Malik, A. Miano-Burkhardt, H. Leonard, H. Iwaki, C. Blauwendraat, A. Singleton, S. Bandres-Ciga (Bethesda, USA)

    Objective: BLAAC PD is a multi-center study recruiting Black and African American individuals with Parkinson’s Disease (PD) and healthy controls. The ultimate goal is to…
  • 2024 International Congress

    Optogenetic Deep Brain Stimulation Rescues Motor Behavior in a Rat Model of Mild Parkinson’s Disease

    A. Kirby, R. Romay-Tallon, A. Brown, C. Gonzalez, TC. Napier (Chicago, USA)

    Objective: To demonstrate feasibility and proof-of-concept for a bilateral rat model of Parkinson’s disease (PD) undergoing deep brain stimulation (DBS) of the subthalamic nucleus (STN)…
  • « Previous Page
  • 1
  • …
  • 118
  • 119
  • 120
  • 121
  • 122
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley